CPRX vs RIVN · P/E 18, rev $491.7M vs rev $1.66B
Catalyst Pharmaceuticals Inc (CPRX) versus Rivian Automotive Inc (RIVN) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Rivian Automotive Inc (RIVN) is a auto manufacturers company listed on NASDAQ. It is led by RJ Scaringe.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported RIVN revenue for 2026-06-30 was $1.66B. Net income was -$833.0M. Revenue was up 20.1% from 2026-03-31 to 2026-06-30. RIVN currently screens at market cap $21.81B.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. RIVN currently screens at market cap $21.81B.
Not investment advice. Open the CPRX and RIVN stock pages for the full models.
Not investment advice.